Sunday, August 20, 2017

INFORMED CONSENT.... A DAY LATE, A DOLLAR SHORT, INCOMPLETE and UNEDUCATED! @JaneAkre AND MESH NEWS DESK ARE A FOUNTAIN OF MISINFORMATION


LANA C. KEETON and her organization, 
TRUTH IN MEDICINE
have been a leading resource for 
#MESH INJURED PATIENTS for over 10 years. 



ALL INFORMATION PUBLISHED BY KEETON AND HER ORGANIZATION HAVE DEEP ROOTS IN SCIENTIFIC STUDIES AND THOUSANDS OF HOURS OF RESEARCH AND INVESTIGATION BASED ON EXPERIENCE AND EXPERTISE, UNLIKE AKRE. 




SEE wwwTRUTHinMEDICINE.us.com for its 
MISSION STATEMENT 
and THE INITIATIVES TO CREATE 
TRUE INFORMED CONSENT
THROUGH CONGRESS
CREATED and WRITTEN 
by Lana C. Keeton and 
PUBLISHED IN 2008. 

Facebook and Jane Akre and her followers want to re-write history. 

Akre's latest on "Informed Consent" (?) for Surgical Mesh for Incontinence and Pelvic Organ Prolapse and Hernia Repair and the Comments Akre publishes from her Anonymous Readers are
A DAY LATE, A DOLLAR SHORT, INCOMPLETE and UNEDUCATED!



PERHAPS IF AKRE ACTUALLY RESEARCHED OR PAID FOR RESEARCH THE INFORMATION ON HER SITE WOULD BE OF MORE VALUE. 

PER DR. DONALD OSTERGARD IN FEBRUARY 2007,
"INFORMED CONSENT CANNOT BE OBTAINED FROM THE PATIENT."

SEE HIS PUBLISHED COMMENTARY FROM FEBRUARY 2007 BELOW:

Dr. Donald R. Ostergard1 Contact Information
(1) 
University of California, Irvine, Long Beach Memorial Medical Center, 701 E. 28th Street, Suite 212, Long Beach, CA 90806, USA
Received: 6 February 2007  
Accepted: 6 February 2007  
Published online: 16 March 2007
Abstract  New procedures and materials for incontinence and prolapse are proliferating rapidly.

Surgical procedures were developed by physicians and carried their names, but over the last 15 years, these procedures are developed by industry and bear the trade names of the companies selling the kits needed to perform them.

The Food and Drug Administration (FDA) approves devices, not procedures, and does not require submission of efficacy or adverse-event data to gain this approval by the 510-K process.

Evidence-based medicine is lacking in the performance of these procedures that may be considered experimental by an insurance company or malpractice carrier with denial of payment or coverage.

Physicians and hospitals are exposing themselves to financial, legal, and ethical risks when performing or allowing such procedures to be performed. Informed consent from the patient cannot be obtained.

We must not confuse medical marketing with evidence-based medicine.


Contact Information
Donald R. Ostergard
Email: catalinaisland1@cs.com

References secured to subscribers.

No comments: